2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type
2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type
About this item
Full title
Author / Creator
US Flu VE Investigators , US Flu VE Investigators , U.S. Flu VE Investigators , Zimmerman, Richard K. , Nowalk, Mary Patricia , Chung, Jessie , Jackson, Michael L. , Jackson, Lisa A. , Petrie, Joshua G. , Monto, Arnold S. , McLean, Huong Q. , Belongia, Edward A. , Gaglani, Manjusha , Murthy, Kempapura , Fry, Alicia M. and Flannery, Brendan
Publisher
United States: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
United States: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Background. Circulating A/H3N2 influenza viruses drifted significantly after strain selection for the 2014-2015 vaccines. Also in 2014-2015, the Advisory committee on Immunization Practices recommended preferential use of live attenuated influenza vaccine (LAIV) over inactivated influenza vaccine (IIV) among children aged 2-8 years. Methods. Vaccin...
Alternative Titles
Full title
2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type
Authors, Artists and Contributors
Author / Creator
US Flu VE Investigators
U.S. Flu VE Investigators
Zimmerman, Richard K.
Nowalk, Mary Patricia
Chung, Jessie
Jackson, Michael L.
Jackson, Lisa A.
Petrie, Joshua G.
Monto, Arnold S.
McLean, Huong Q.
Belongia, Edward A.
Gaglani, Manjusha
Murthy, Kempapura
Fry, Alicia M.
Flannery, Brendan
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5146719
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5146719
Other Identifiers
ISSN
1058-4838
E-ISSN
1537-6591
DOI
10.1093/cid/ciw635
